Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema (bilateral)
ICD-10 E09.3213 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema (bilateral).
E09.3213 refers to diabetes mellitus that is induced by drugs or chemicals, characterized by the presence of mild nonproliferative diabetic retinopathy and bilateral macular edema. This condition arises when certain medications, such as glucocorticoids or antipsychotics, disrupt normal glucose metabolism, leading to hyperglycemia and subsequent diabetes. The mild nonproliferative diabetic retinopathy indicates early retinal changes due to diabetes, where small blood vessels in the retina become damaged, but without significant vision loss. Bilateral macular edema signifies fluid accumulation in the macula, the central part of the retina, which can lead to blurred vision. Management of this condition often involves controlling blood glucose levels through lifestyle modifications and medications, monitoring HbA1c levels to assess long-term glucose control, and addressing the ocular complications through regular eye examinations and potential treatments such as anti-VEGF injections or laser therapy.
Detailed medication history, HbA1c levels, and management plans.
Patients presenting with hyperglycemia after starting new medications.
Ensure clear documentation of the drug responsible for diabetes.
Detailed retinal examination findings, including the extent of retinopathy and edema.
Patients with diabetes presenting for routine eye exams showing retinal changes.
Document the severity and bilateral nature of retinopathy and edema.
Used for routine eye exams in diabetic patients.
Document visual acuity, retinal findings, and any treatments provided.
Ophthalmologists should ensure comprehensive documentation of diabetic changes.
Medications such as glucocorticoids, thiazide diuretics, and certain antipsychotics are known to induce diabetes by affecting insulin secretion or action.